Resultats de la cerca - Kristine Griffett

  • Mostrar 1 - 7 resultats de 7
Refinar resultats
  1. 1
    Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases

    Development of LXR inverse agonists to treat MAFLD, NASH, and other metabolic diseases per Kristine Griffett, Thomas P. Burris

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis

    The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis per Kristine Griffett, Ryan D. Welch, Colin A. Flaveny, Grant R. Kolar, Brent A. Neuschwander‐Tetri, Thomas P. Burris

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Nuclear Receptors and Their Selective Pharmacologic Modulators

    Nuclear Receptors and Their Selective Pharmacologic Modulators per Thomas P. Burris, Laura A. Solt, Yongjun Wang, Christine Crumbley, Subhashis Banerjee, Kristine Griffett, Thomas Lundåsen, Travis Hughes, Douglas J. Kojetin

    Publicat 2013
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis

    Broad Anti-tumor Activity of a Small Molecule that Selectively Targets the Warburg Effect and Lipogenesis per Colin A. Flaveny, Kristine Griffett, Bahaa Elgendy, Melissa Kazantzis, Monideepa Sengupta, Antonio L. Amelio, Arindam Chatterjee, John K. Walker, Laura A. Solt, Theodore M. Kamenecka, Thomas P. Burris

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour

    Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour per Subhashis Banerjee, Yongjun Wang, Laura A. Solt, Kristine Griffett, Melissa Kazantzis, Ariadna Amador, Bahaa M. El-Gendy, Salvador Huitrón‐Reséndiz, Amanda J. Roberts, Youseung Shin, Theodore M. Kamenecka, Thomas P. Burris

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Mitochondrial pyruvate carrier inhibitors improve metabolic parameters in diet-induced obese mice

    Mitochondrial pyruvate carrier inhibitors improve metabolic parameters in diet-induced obese mice per Wesley T. Hodges, Chaowapong Jarasvaraparn, Daniel Ferguson, Kristine Griffett, Lauren E. Gill, Yana Chen, Ma. Xenia G. Ilagan, Lamees Hegazy, Bahaa Elgendy, Kevin Cho, Gary J. Patti, Kyle S. McCommis, Brian N. Finck

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023

    International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023 per Thomas P. Burris, Ian Mitchelle S. de Vera, Isabelle Côté, Colin A. Flaveny, Udayanga Wanninayake, Arindam Chatterjee, John K. Walker, Nickolas Steinauer, Jinsong Zhang, Laurel A. Coons, Kenneth S. Korach, Derek W. Cain, Anthony N. Hollenberg, Paul Webb, Douglas Forrest, Anton M. Jetten, Dean P. Edwards, Sandra L. Grimm, Sean M. Hartig, Carol A. Lange, Jennifer K. Richer, Carol A. Sartorius, Marc J. Tetel, Cyrielle Billon, Bahaa Elgendy, Lamees Hegazy, Kristine Griffett, Nahuel Peinetti, Kerry L. Burnstein, Travis Hughes, Sadichha Sitaula, Keitch R. Stayrook, Alexander Culver, Meghan H. Murray, Brian N. Finck, John A. Cidlowski

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:

Eines de cerca: